---
figid: PMC8044749__fimmu-12-650184-g001
figlink: pmc/articles/PMC8044749/figure/f1/
number: F1
caption: Proposed immunopathological roles of circulating histones in sepsis. In sepsis,
  inflammatory mediators including pathogen associated molecule patterns (PAMPs, namely
  bacteria and LPS etc.) and damage associated molecule patterns (DAMPs, namely IL-18,
  TNF-α and high mobility group box 1 etc.) activate innate immune cells (neutrophils
  and macrophages) and endothelial cells through pattern recognition receptors (toll-like
  receptors, C-type lectin receptors, and NOD-like receptors), initiating transcription
  of type I interferons and proinflammatory cytokines and triggering highly inflammatory
  programmed cell death such as NETosis/ETosis, necroptosis, necrosis and pyroptosis.
  Rupture of the plasma cell membrane of these cells contributes to the release of
  histones into extracellular spaces. Histones trigger innate immunity by activating
  Toll-like receptor (TLR) 2/4/9 or NLPR3 inflammasome pathways, leading to the release
  of pro-inflammatory cytokines (IL-1, IL-1β, IL-6, IL-18, TNF-α etc.) that not only
  cause neutrophils to release extracellular traps in return but also upregulate tissue
  factor (TF) expression by blood monocytes. Histones bind to endothelium cells and
  cause cell permeabilization, calcium influx and endothelium injury. Endothelium
  injury further induces barrier dysfunction, leakage of plasma-protein-rich fluid
  into the tissues, alteration of blood flow dynamics, recruitment and activation
  of circulating leucocytes and release of excessive cytokines, which are characterized
  by increased TF, prostacyclin (PGI2) and superoxide expression, decreased thromboxane
  A2 (TXA2) and nitric oxide release. Increased TF can trigger the activation of prothrombin
  through extrinsic coagulation pathway and finally cause disseminated intravenous
  coagulation (DIC). Besides, histones can directly activate thrombin formation by
  binding to prothrombin fragments 1 and 2 to form histone-prothrombin-FXa complex.
  Histones also induce platelet aggregation, activation and subsequent platelet-dependent
  thrombin formation through TLR2 and TLR4 pathways. Finally, dysregulated inflammation
  response, impaired endothelial barrier, immunothrombosis and DIC collectively cause
  multiple organ dysfunction (MODS) including circulatory failure, acute respiratory
  distress syndrome (ARDS), renal failure and liver failure, resulting in death in
  most severe form of sepsis.
pmcid: PMC8044749
papertitle: 'Circulating Histones in Sepsis: Potential Outcome Predictors and Therapeutic
  Targets.'
reftext: Yupei Li, et al. Front Immunol. 2021;12:650184.
pmc_ranked_result_index: '124133'
pathway_score: 0.8982092
filename: fimmu-12-650184-g001.jpg
figtitle: Proposed immunopathological roles of circulating histones in sepsis
year: '2021'
organisms:
- Mus musculus
- Rattus norvegicus
- Streptococcus sp. group A
- Mannheimia haemolytica
- Homo sapiens
- Canis lupus familiaris
- Bos taurus
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8044749__fimmu-12-650184-g001.html
  '@type': Dataset
  description: Proposed immunopathological roles of circulating histones in sepsis.
    In sepsis, inflammatory mediators including pathogen associated molecule patterns
    (PAMPs, namely bacteria and LPS etc.) and damage associated molecule patterns
    (DAMPs, namely IL-18, TNF-α and high mobility group box 1 etc.) activate innate
    immune cells (neutrophils and macrophages) and endothelial cells through pattern
    recognition receptors (toll-like receptors, C-type lectin receptors, and NOD-like
    receptors), initiating transcription of type I interferons and proinflammatory
    cytokines and triggering highly inflammatory programmed cell death such as NETosis/ETosis,
    necroptosis, necrosis and pyroptosis. Rupture of the plasma cell membrane of these
    cells contributes to the release of histones into extracellular spaces. Histones
    trigger innate immunity by activating Toll-like receptor (TLR) 2/4/9 or NLPR3
    inflammasome pathways, leading to the release of pro-inflammatory cytokines (IL-1,
    IL-1β, IL-6, IL-18, TNF-α etc.) that not only cause neutrophils to release extracellular
    traps in return but also upregulate tissue factor (TF) expression by blood monocytes.
    Histones bind to endothelium cells and cause cell permeabilization, calcium influx
    and endothelium injury. Endothelium injury further induces barrier dysfunction,
    leakage of plasma-protein-rich fluid into the tissues, alteration of blood flow
    dynamics, recruitment and activation of circulating leucocytes and release of
    excessive cytokines, which are characterized by increased TF, prostacyclin (PGI2)
    and superoxide expression, decreased thromboxane A2 (TXA2) and nitric oxide release.
    Increased TF can trigger the activation of prothrombin through extrinsic coagulation
    pathway and finally cause disseminated intravenous coagulation (DIC). Besides,
    histones can directly activate thrombin formation by binding to prothrombin fragments
    1 and 2 to form histone-prothrombin-FXa complex. Histones also induce platelet
    aggregation, activation and subsequent platelet-dependent thrombin formation through
    TLR2 and TLR4 pathways. Finally, dysregulated inflammation response, impaired
    endothelial barrier, immunothrombosis and DIC collectively cause multiple organ
    dysfunction (MODS) including circulatory failure, acute respiratory distress syndrome
    (ARDS), renal failure and liver failure, resulting in death in most severe form
    of sepsis.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL16
  - IRF6
  - TNF
  - IL18
  - COX4I1
  - COX6A1
  - COX6A2
  - COX6B1
  - COX7A1
  - COX7A2
  - COX8A
  - COX10
  - COX11
  - COX5A
  - COX17
  - COX4I2
  - COX8C
  - COX5B
  - COX7B
  - COX15
  - COX6B2
  - COX7B2
  - NOS1
  - NOS2
  - NOS3
  - TLR1
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR8
  - TLR9
  - TLR2
  - TLR7
  - TLR10
  - TF
  - IL6
  - IL1A
  - IL1B
  - PGI2
  - superoxide
  - TXA2
  - nitric oxide
  - LPS
  - von Willebrand
  - coagulopathy
  - Organ failure
  - Circulatory failure
  - Renal failure
  - Liver failure
  - MODS
genes:
- word: IL-16,
  symbol: IL-16
  source: hgnc_alias_symbol
  hgnc_symbol: IL16
  entrez: '3603'
- word: LPS,
  symbol: LPS
  source: hgnc_prev_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: suchasbacteria,LPS,IL-16,IL-18andTNF-a)
  symbol: IL-16
  source: hgnc_alias_symbol
  hgnc_symbol: IL16
  entrez: '3603'
- word: suchasbacteria,LPS,IL-16,IL-18andTNF-a)
  symbol: LPS
  source: hgnc_prev_symbol
  hgnc_symbol: IRF6
  entrez: '3664'
- word: TNF-a
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: IL-18
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: cox-
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX4I1
  entrez: '1327'
- word: cox-
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX6A1
  entrez: '1337'
- word: cox-
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX6A2
  entrez: '1339'
- word: cox-
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX6B1
  entrez: '1340'
- word: cox-
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX7A1
  entrez: '1346'
- word: cox-
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX7A2
  entrez: '1347'
- word: cox-
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX8A
  entrez: '1351'
- word: cox-
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX10
  entrez: '1352'
- word: cox-
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX11
  entrez: '1353'
- word: cox-
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX5A
  entrez: '9377'
- word: cox-
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX17
  entrez: '10063'
- word: cox-
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX4I2
  entrez: '84701'
- word: cox-
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX8C
  entrez: '341947'
- word: cox-
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX5B
  entrez: '1329'
- word: cox-
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX7B
  entrez: '1349'
- word: cox-
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX15
  entrez: '1355'
- word: cox-
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX6B2
  entrez: '125965'
- word: cox-
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX7B2
  entrez: '170712'
- word: NOS
  symbol: NOS
  source: bioentities_symbol
  hgnc_symbol: NOS1
  entrez: '4842'
- word: NOS
  symbol: NOS
  source: bioentities_symbol
  hgnc_symbol: NOS2
  entrez: '4843'
- word: NOS
  symbol: NOS
  source: bioentities_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR1
  entrez: '7096'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR3
  entrez: '7098'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR4
  entrez: '7099'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR5
  entrez: '7100'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR6
  entrez: '10333'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR8
  entrez: '51311'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR9
  entrez: '54106'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR2
  entrez: '7097'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR7
  entrez: '51284'
- word: TLR
  symbol: TLR
  source: bioentities_symbol
  hgnc_symbol: TLR10
  entrez: '81793'
- word: TF,PGI2,vonWillebrandfactor
  symbol: TF
  source: hgnc_symbol
  hgnc_symbol: TF
  entrez: '7018'
- word: TF,
  symbol: TF
  source: hgnc_symbol
  hgnc_symbol: TF
  entrez: '7018'
- word: IL-1,IL-18,IL-6,IL-18,TNF-a
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
- word: IL-1,IL-18,IL-6,IL-18,TNF-a
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: IL-1,IL-18,IL-6,IL-18,TNF-a
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: IL-1,IL-18,IL-6,IL-18,TNF-a
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: IL-6,
  symbol: IL-6
  source: hgnc_alias_symbol
  hgnc_symbol: IL6
  entrez: '3569'
- word: TNF-a
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: IL-1,
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: IL-1,
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: IL-18,
  symbol: IL-18
  source: hgnc_alias_symbol
  hgnc_symbol: IL18
  entrez: '3606'
chemicals:
- word: PGI2
  source: MESH
  identifier: D011464
- word: superoxide
  source: MESH
  identifier: D013481
- word: TXA2
  source: MESH
  identifier: D014148
- word: nitric oxide
  source: MESH
  identifier: D009569
diseases:
- word: LPS
  source: MESH
  identifier: C536528
- word: von Willebrand
  source: MESH
  identifier: D014842
- word: coagulopathy
  source: MESH
  identifier: D001778
- word: Organ failure
  source: MESH
  identifier: D009102
- word: Circulatory failure
  source: MESH
  identifier: D012769
- word: Renal failure
  source: MESH
  identifier: D051437
- word: Liver failure
  source: MESH
  identifier: D017093
- word: MODS
  source: MESH
  identifier: D009102
figid_alias: PMC8044749__F1
redirect_from: /figures/PMC8044749__F1
figtype: Figure
---
